# Synthetic cannabinoids cause more convulsion and hypothermia in mice than cannabis-derived cannabinoids. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/synthetic-cannabinoids-toxicity-convulsions-hypothermia-mice/ > **Published:** 2021-05-18T14:30:36-04:00 | **Last Modified / Clinically Audited:** 2026-09-05T08:07:41-04:00 > **Clinical Summary:** Explore synthetic cannabinoids toxicity causing convulsions and hypothermia in mice, highlighting risks compared to cannabis-derived cannabinoids. --- ### Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with D9-Tetrahydrocannabinol In Summary [Synthetic cannabinoids](https://cedclinic.com/synthetic-cannabinoid-parkinsons-trial-ser-252-funding/) are commonly used as recreational drugs. However, an increasing number of clinical reports have documented seizures and even death following [synthetic cannabinoids](https://cedclinic.com/synthetic-cannabinoid-parkinsons-trial-ser-252-funding/) use. Therefore, the need to examine the effects of these compounds on various biological systems is urgent. In a recent study, scientists employed mice to compare the toxicity of several synthetic cannabinoids, AM-2201, CP55940, JWH-073, HU-210 with THC and cannabidiol – a psychoactive and a non-psychoactive constituent of the plant cannabis, respectively. Mice were given daily injections of each of these compounds and assessed for convulsion and hypothermia, or decrease in body temperature – symptoms corresponding to seizures in humans. The study results indicated that AM-2201 and JWH-073 produced significantly more convulsions and all synthetic cannabinoids produced significantly more hypothermia than THC and CBD. To follow-up, the researchers pre-treated mice with either a blocker of the [cannabinoid receptor type 1](https://cedclinic.com/mediation-of-the-cannabinoid-receptor-type-1-can-enhance-the-antidepressant-powers-of-conventional-therapy/) (CB1) or a blocker of the cannabinoid receptor type 2 (CB2), and then administered similar doses of the above compounds. While both are bound and activated by cannabinoids, CB1 is widely expressed in the brain and CB2 in cells of the [immune system](https://cedclinic.com/fungal-contamination-cannabis-risks-arizona-preroll-recall/). The researchers found that when CB1 was blocked, the convulsions and hypothermia induced by most compounds were prevented but this was not the case for CB2. Such data suggested that the synthetic cannabinoids exert their adverse effects through activation of receptors in the brain, although the exact mechanisms remain a topic of further study. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [The Endocannabinoid System and Myelin Regeneration: A Clinical Breakdown](https://cedclinic.com/cb1-receptor-myelin-repair-endocannabinoid-system/) Learn how the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) influences myelin repair and [neurological health](https://cedclinic.com/benzodiazepine-discontinuation-rates-medical-cannabis/). [Read More](https://cedclinic.com/cb1-receptor-myelin-repair-endocannabinoid-system/) [The endocannabinoid system controls various functions of the olfactory circuit](https://cedclinic.com/the-endocannabinoid-system-controls-various-functions-of-the-olfactory-circuit/) Explore the role of the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) in regulating olfactory functions and brain signaling. [Discover Insights](https://cedclinic.com/the-endocannabinoid-system-controls-various-functions-of-the-olfactory-circuit/) [A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling.](https://cedclinic.com/cannabis-essential-oil-neuroinflammation-multiple-sclerosis-study/) Study the neuroprotective effects of cannabis essential oil in autoimmune neuroinflammation models. [Explore Study](https://cedclinic.com/cannabis-essential-oil-neuroinflammation-multiple-sclerosis-study/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Synthetic%20cannabinoids%20cause%20more%20convulsion%20and%20hypothermia%20in%20mice%20than%20cannabis-derived%20cannabinoids.&url=https%3A%2F%2Fcedclinic.com%2Fsynthetic-cannabinoids-toxicity-convulsions-hypothermia-mice%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fsynthetic-cannabinoids-toxicity-convulsions-hypothermia-mice%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Synthetic%20cannabinoids%20cause%20more%20convulsion%20and%20hypothermia%20in%20mice%20than%20cannabis-derived%20cannabinoids.%20https%3A%2F%2Fcedclinic.com%2Fsynthetic-cannabinoids-toxicity-convulsions-hypothermia-mice%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).